ArticleInflammation2026
Integrated Transcriptomic Analysis Identifies TAP1 as a Key Regulator of PANoptosis in Diabetic Kidney Disease Tubular Injury.
Article in Inflammation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Targeting pyroptosis in renal fibrosis: From molecular mechanisms to therapeutic horizons (Review).International journal of molecular medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Tubular injury is a key driver of diabetic kidney disease (DKD) progression. However, the involvement and regulatory mechanisms of PANoptosis in diabetic tubular injury remain poorly defined. Utilizing transcriptomic datasets from DKD renal tubules, we identified differentially expressed genes (DEGs) through limma analysis and co-expression modules via weighted gene co-expression network analysis (WGCNA). These findings were intersected with a comprehensive PANoptosis-related gene set. Hub genes were further prioritized using machine learning algorithms, including LASSO regression and random forest. Validation was conducted through the Nephroseq database, single-cell RNA sequencing (scRNA-seq) analysis and experimental studies in high glucose-treated tubular cells, DKD mice, and human DKD biopsies. Furthermore, functional enrichment and immune infiltration analyses were performed to elucidate biological implications. We revealed 1,624 DEGs and two key WGCNA modules significantly associated with DKD. Among 31 PANoptosis-related DEGs, machine learning prioritized three hub genes (TAP1, CASP1, PRKX), all of which were significantly upregulated in DKD and exhibited negative correlations with glomerular filtration rate. Functional analyses linked these hub genes to inflammatory and immune responses and scRNA-seq data confirmed their overexpression in proximal tubular cells. Moreover, experimental validation consistently demonstrated TAP1 upregulation in tubular cells under high glucose conditions, kidney tissues from DKD mouse models and human DKD biopsy samples. Our integrated analysis identifies TAP1 as a crucial regulator of PANoptosis in injured renal tubules of DKD, providing novel mechanistic insights into the pathogenesis of tubular injury and a potential therapeutic target for future research.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.